Noticias de BNGO_US
Noticias del mercado
Últimas noticias sobre BNGO_US — 111 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Bionano Genomics Inc (BNGO) Q1 2026 Earnings Call Highlights: Re
Bionano outlines $30M-$33M 2026 revenue guidance as it expects flow cell supply to improve
Bionano Genomics Inc reports results for the quarter ended March 31 - Earnings Summary
BNGO: Q1 2026 saw 4% revenue growth, record flow cell sales, and improved gross margin, with strong outlook
Bionano Genomics, Inc. (BNGO) Reports Q1 Loss, Tops Revenue Estimates
Earnings call transcript: Bionano Genomics Q1 2026 shows revenue growth
BNGO: Q1 2026 saw revenue and margin growth, record flow cell sales, and strengthened reimbursement
Is Bionano Genomics (BNGO) Undervalued After Q1 2026? EPS not di
Transcript: Bionano Genomics Q1 2026 Earnings Conference Call
Bionano Genomics (NASDAQ: BNGO) posts Q1 2026 loss and warns on going concern
Bionano Reports First Quarter 2026 Results and Provides a Business Update
Bionano Genomics (BNGO) posts Q1 2026 loss on $6.7M revenue and lifts OGM reimbursement
Bionano Genomics Q4 2026 earnings preview
TradingKey
Bionano Genomics Inc (BNGO) Q1 2026 Earnings Report Preview: Wha
BNGO (Bionano Genomics, Inc.) anunciará sus resultados del primer trimestre de 26 el 13 de mayo, antes de la apertura del mercado. Se espera que las ganancias se revelen a las 4:00 p.m. ET (8:00 p.m. UTC). Para el primer trimestre de 2026, la estimación de ingresos es de 6,57 millones de dólares y el EPS (ganancia por acción) previsto es de (0,88) dólares. Conozca más detalles en…
Bionano Genomics Inc expected to post a loss of 95 cents a share - Earnings Preview
Bionano raises 2025 OGM installation target to 25 as consumables and software revenue climbs 16%
Página 1 de 6
